IRADIMED CORP (IRMD) Stock

HealthcareMedical Devices Website

IRMD has an Alpha Score of 39 out of 100 (weak), computed on Nov 7, 2026 from 3 of 4 sub-scores. 3 of the hedge funds AlphaScala tracks reported IRMD in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Renaissance Technologies's at $37.69M. Company insiders reported 0 open-market buys and 2 sales on SEC Form 4 in the 90 days to Nov 6, 2026. Its trailing P/E ratio is 45.6 and its net margin 26.9% (key statistics as of Nov 7, 2026).

$86.31
+0.90%
Last price
Source: Finnhub
Alpha Score
39
Weak

What is IRMD's Alpha Score?

How it works →

Alpha Score of 39 reflects weak overall profile with weak momentum, poor value, strong quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.

Momentum
38
Weak
Value
18
Poor
Quality
75
Strong

Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.

Computed Nov 7, 2026

A rules-based research rating, not a recommendation to buy or sell.

Which hedge funds own IRMD?

From 13F filings
FundShares HeldPosition ValueChange vs prior Q
Renaissance Technologies
Jim Simons (founder)
394K$37.69M-11%
Marshall Wace25K$2.42MNEW
Point72
Steve Cohen
12K$1.14M-17%

13F holdings as of Jun 30, 2026

Explore all tracked funds →

Are IRADIMED CORP insiders buying or selling?

SEC Form 4 filings
90 days to Nov 6, 2026
Buys
0
Sells
2
Net $
-$123K
Unique insiders
1
DateInsiderRoleTypeSharesValue
Sep 3, 26Allen Monty KDirectorSELL1.0K$88K
Sep 3, 26Allen Monty KDirectorSELL405$35K

SEC Form 4 filings as of Nov 6, 2026

See cluster-buy signals across all tickers →

What are IRMD's key statistics?

P/E Ratio
45.61
EPS (TTM)
1.86
Beta
0.91
Net Margin
26.85%
ROE
23.90%
Debt / Equity
0.00
52W High
$107.90
52W Low
$76.35

Key statistics as of Nov 7, 2026

How does IRMD's valuation compare with the Healthcare sector?

MetricIRMDHealthcare medianCompanies in median
P/E ratio45.628.8113
Net margin26.85%3.66%170
Return on equity23.90%3.71%194

Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 9, 2026). P/E excludes loss-making companies.

IRMD price chart

Powered by TradingView

What does IRADIMED CORP do?

Iridium Corporation is a leading communications technology company specializing in satellite-based mobile voice and data communication services. The company's core purpose is to facilitate global connectivity through a comprehensive network of 66 low earth orbit satellites, providing unrivaled coverage across oceans, airways, and polar regions. This extensive satellite constellation enables Iridium to offer robust and reliable communication solutions for industries such as maritime, aviation, government, emergency services, and enterprise sectors. Notably, Iridium's services are crucial for remote operations and disaster response efforts, where traditional communication infrastructure is inadequate or non-existent. Their product range includes satellite phones, broadband solutions, IoT connectivity, and integrated communication systems designed to ensure secure and uninterrupted communication. With a focus on innovation and adaptability, Iridium continues to play a significant role in advancing satellite communications, making critical communications accessible worldwide, and empowering users to maintain connectivity in even the most challenging environments.

CEO
Mr. Roger E. Susi
Employees
160
Market Cap
$1.09B
Ask about IRMDAI research agent